Countouriotis Athena 4
4 · Passage BIO, Inc. · Filed May 23, 2024
Insider Transaction Report
Form 4
Countouriotis Athena
Director
Transactions
- Award
Director Stock Option (right to buy)
2024-05-21+47,693→ 47,693 totalExercise: $1.28Exp: 2034-05-21→ Common Stock (47,693 underlying)
Footnotes (1)
- [F1]The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2025 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.